GLP-1 & Metabolic Peptide Research
GLP-1 and related incretin peptides are among the most intensively studied compounds in metabolic research. In laboratory and animal models, researchers investigate how single, dual and triple receptor agonists engage the GLP-1, GIP and glucagon pathways, and how amylin analogs and other metabolic peptides influence energy-balance and glucose-handling signalling. Understanding these mechanisms is a rapidly expanding field.
This pillar compares the incretin and metabolic peptides most frequently studied, from single-receptor agonists through triple agonists, and links each to its product page. Every compound from Amino Labs is lyophilized, 99%+ HPLC-verified, third-party tested and shipped across Canada via Purolator.
This content frames these peptides purely as tools for metabolic research. It does not describe weight-loss, therapeutic or human use of any kind. All material is supplied for research use only, not for human or animal consumption, and nothing here is medical or dosing guidance.
Recommended Products
Metabolic Research Peptides Compared
The table below groups metabolic peptides by receptor mechanism. Follow each link for full specifications.
| Compound | Mechanism class | Research focus |
|---|---|---|
| Semaglutide 10mg | Single agonist (GLP-1) | Incretin-pathway and glucose-signalling models |
| Tirzepatide 10mg | Dual agonist (GLP-1/GIP) | Combined incretin-receptor research |
| Retatrutide 10mg | Triple agonist (GLP-1/GIP/glucagon) | Multi-receptor metabolic models |
| Cagrilintide 10mg | Amylin analog | Amylin-pathway and satiety-signalling research |
| AOD-9604 10mg | GH-fragment peptide | Lipid-metabolism research models |
| MOTS-c 40mg | Mitochondrial-derived peptide | Mitochondrial and metabolic-regulation studies |
| 5-Amino-1MQ 10mg | NNMT inhibitor | NAD and adipocyte-metabolism research |
| SLU-PP-332 5mg | ERR agonist | Mitochondrial-oxidation research models |
The incretin agonists differ by how many receptors they engage: Semaglutide targets GLP-1 alone, Tirzepatide adds GIP, and Retatrutide adds glucagon for triple activity. Cagrilintide works through the distinct amylin pathway and is often studied alongside GLP-1 agonists. Beyond incretins, AOD-9604, MOTS-c, 5-Amino-1MQ and SLU-PP-332 give researchers additional tools for exploring lipid, mitochondrial and NAD-related metabolic pathways.
Selecting & Handling Metabolic Peptides
Researchers choose among these compounds based on the receptor mechanism their study targets. Single-agonist work isolates GLP-1 signalling cleanly, while dual and triple agonists suit investigations of combined incretin pathways. Amylin analogs and mitochondrial peptides open separate lines of metabolic inquiry, and are sometimes studied in combination to model pathway interaction.
Because these peptides are peptide-based, storage and reconstitution follow standard practice: keep lyophilized vials cold and protected from light, reconstitute with bacteriostatic water using a dedicated reconstitution kit, and label solutions with concentration and date. Prepare working aliquots to limit freeze-thaw cycles and record lot numbers for reproducibility.
Sourcing HPLC-verified, third-party-tested material from a Canadian-owned supplier reduces batch variability, which is essential when comparing metabolic outcomes across models. All compounds are supplied for research use only, not for human or animal consumption.